Skip to content

A multicenter prospective cohort study of Qikui Granules for the treatment of diabetic kidney disease

A multicenter prospective cohort study of Qikui Granules for the treatment of diabetic kidney disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2024000591
Enrollment
Unknown
Registered
2024-10-21
Start date
2024-11-01
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic kidney disease

Interventions

non-exposed group(do not use Qikui Granules):N/A
exposed group(use Qikui Granules):N/A

Sponsors

Jiangsu Province Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Meets the diagnostic criteria of DKD A2G1~A3G3; 2.The syndrome differentiation in traditional Chinese medicine is deficiency of Qi and Yin and dampness and blood stasis blocking collaterals type; 3.Aged 18~75 years old, regardless of gender; 4. HbA1c <8%, BP <160/90mmHg; 5.The patients were informed and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1.Combination of other causes of chronic kidney disease; 2.Patients with diabetic ketoacidosis, Hyperosmolar hyperglycemic syndrome, severe infection within the past month; 3.Patients with unilateral or bilateral renal artery stenosis history; 4.Taking Qikui Granules within 1 month; 5.Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
24-hour urinary total protein, UTP;urinary albumin/creatinine ratio,UACR;

Secondary

MeasureTime frame
neutrophil gelatinase associated lipocalin,NGAL;estimated glomerular filtration rate, eGFR;high-density lipoprotein cholesterol, HDL-C;glycated hemoglobin, A1c, HbA1c;TCM syndrome score;fasting blood glucose, FBG;total cholesterol, TC;fasting C-peptide;Triglyceride, TG;low-density lipoprotein cholesterol, LDL-C;kidney injury molecule-1, KIM-1;

Countries

China

Contacts

Public ContactJiangyi Yu

Jiangsu Province Hospital of Chinese Medicine

yjy202105@njucm.edu.cn+86 13951704703

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026